![Andreas Hadjivasiliou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Andreas Hadjivasiliou holds the position of Managing Analyst at Evaluate Ltd.
He has been part of the Evaluate team for almost 10 years.
He has a background in designing SaaS products in the B2B space, driving insights for clients and supporting operational excellence.
Aktive Positionen von Andreas Hadjivasiliou
Unternehmen | Position | Beginn |
---|---|---|
Evaluate Ltd.
![]() Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Analyst-Equity | 01.09.2012 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Evaluate Ltd.
![]() Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Finance |